首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1542458

全球生物可吸收支架市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Bioabsorbable Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球生物可吸收支架市場需求預計將從2023年的4.6022億美元達到近8.3407億美元的市場規模，2024-2032年研究期間複合年成長率為6.83%。

生物可吸收支架插入人體血管以防止或減輕阻塞，並在適當的時候被人體吸收或溶解。理想的支架應具有優異的機械性能，以在所需的時間內提供必要的血管支撐。它必須具有生物相容性，具有良好的遞送能力以攜帶抗增殖藥物以減少再狹窄，並且具有足夠的分解時間。經過一段特定的時間後，支架會透過重建血管的正常形態和生理學（運動性、血管幾何形狀和剪切應力）而消失，而不會產生強烈的發炎反應。支架的成功很大程度取決於材料的選擇和設計。可吸收支架是介入性心臟病學領域最有前途的器材之一。

市場動態

心血管疾病的高盛行率和全球人口對微創手術的偏好增加將是生物可吸收支架市場成長的關鍵趨勢因素。高可支配收入和對技術先進的治療方法的偏好將促進市場成長。使用這些支架透過減少患者血栓形成的機會和雙重抗血小板治療來提高治療效率將是市場的助推器。老年人口的增加以及由於不健康的生活方式而導致的冠狀動脈疾病風險的增加將有利於市場的成長。與該技術開發相關的巨額投資以及支架植入術對人體的不良影響將是該市場成長的主要障礙。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球生物可吸收支架市場的各個細分市場進行了包容性評估。生物可吸收支架產業的成長和趨勢為本研究提供了整體方法。

市場區隔

生物可吸收支架市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

透過生物材料

生物可吸收聚合物支架
生物可吸收金屬支架

按申請

冠狀動脈疾病
周邊動脈疾病

按吸收率

分段吸收速度慢
吸收速度快

按最終用戶

醫院
心臟中心
門診手術中心

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的生物可吸收支架市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。生物可吸收支架市場的主要參與者包括 Amaranth Medical、Arterial Remodeling Technologies、Arterius Limited、B.Braun Melsungen AG、Biotronik SE & Co. KG、Boston Scientific Corporation、Elixir Medical Corporation、Kyoto Medical Planning Co. Ltd、Microport Scientific公司、Reva Medical、Terumo Corporation。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 生物材料的市場吸引力分析
- 市場吸引力分析：依應用分類
- 以吸收率分析市場吸引力
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球生物可吸收支架市場分析：依生物材料

生物材料概述
歷史和預測數據
生物材料分析
生物可吸收聚合物支架
生物可吸收金屬支架

第 6 章：全球生物可吸收支架市場分析：依應用分類

概述：按應用
歷史和預測數據
分析：按應用
冠狀動脈疾病
周邊動脈疾病

第 7 章：全球生物可吸收支架市場分析：依吸收率

按吸收率概述
歷史和預測數據
按吸收率分析
分段吸收速度慢
吸收速度快

第 8 章：全球生物可吸收支架市場分析：依最終用戶分類

最終用戶概述
歷史和預測數據
最終用戶分析
醫院
心臟中心
門診手術中心

第 9 章：全球生物可吸收支架市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：生物可吸收支架公司的競爭格局

生物可吸收支架市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Amaranth Medical

公司概況
公司收入
產品
最新動態

Arterial Remodeling Technologies

公司概況
公司收入
產品
最新動態

Arterius Limited

公司概況
公司收入
產品
最新動態

B.Braun Melsungen AG

公司概況
公司收入
產品
最新動態

Biotronik SE & Co. KG

公司概況
公司收入
產品
最新動態

Boston Scientific Corporation

公司概況
公司收入
產品
最新動態

Elixir Medical Corporation

公司概況
公司收入
產品
最新動態

Kyoto Medical Planning Co. Ltd.

公司概況
公司收入
產品
最新動態

Microport Scientific Corporation

公司概況
公司收入
產品
最新動態

Reva Medical

公司概況
公司收入
產品
最新動態

Terumo Corporation

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213618

The global demand for Bioabsorbable Stents Market is presumed to reach the market size of nearly USD 834.07 Million by 2032 from USD 460.22 Million in 2023 with a CAGR of 6.83% under the study period 2024-2032.

Bioabsorbable stents are inserted into a human blood vessel to prevent or alleviate a blockage and are absorbed or dissolved by the body in due course. An ideal stent should have superior mechanical properties to provide the necessary vessel support during the required period. It must be biocompatible, have good deliverability to carry an antiproliferative drug to reduce restenosis, and have adequate degradation time. After a specific period, the stent disappears by re-establishing the normal morphology and physiology (motility, vessel geometry, and shear stress) of the blood vessel without creating an intense inflammatory response. The success of a stent largely depends on the selection of the material and the design. Absorbable stents are one of the most promising devices in the field of interventional cardiology.

MARKET DYNAMICS

High prevalence of cardiovascular disorders and increased preference for minimally invasive procedures among the global population will be the critical trending factors for the growth of the bioabsorbable stents market. High disposable income and inclination toward technologically advanced treatment methods will boost market growth. The increased efficiency of the treatment using these stents by reducing the chances of thrombosis and dual antiplatelet therapy among patients will be a market booster. The increasing geriatric population and the increased risk of coronary artery diseases due to unhealthy lifestyles will benefit market growth. The massive investments associated with this technology's development and the undesirable effects of stenting in the human body will be the major hurdles for this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bioabsorbable Stents. The growth and trends of Bioabsorbable Stents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Bioabsorbable Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Biomaterial

Bioabsorbable Polymer-based Stents
Bioabsorbable Metallic Stents

By Application

Coronary Artery Disease
Peripheral Artery Disease

By Absorption Rate

Segmentation Slow Absorption Rate
Fast Absorption Rate

By End-user

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Bioabsorbable Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bioabsorbable Stents market include Amaranth Medical, Arterial Remodeling Technologies, Arterius Limited, B.Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Microport Scientific Corporation, Reva Medical, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOABSORBABLE STENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Biomaterial
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Absorption Rate
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY BIOMATERIAL

5.1. Overview By Biomaterial
5.2. Historical and Forecast Data
5.3. Analysis By Biomaterial
5.4. Bioabsorbable Polymer-based Stents Historic and Forecast Sales By Regions
5.5. Bioabsorbable Metallic Stents Historic and Forecast Sales By Regions

6. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Coronary Artery Disease Historic and Forecast Sales By Regions
6.5. Peripheral Artery Disease Historic and Forecast Sales By Regions

7. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY ABSORPTION RATE

7.1. Overview By Absorption Rate
7.2. Historical and Forecast Data
7.3. Analysis By Absorption Rate
7.4. Segmentation Slow Absorption Rate Historic and Forecast Sales By Regions
7.5. Fast Absorption Rate Historic and Forecast Sales By Regions

8. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data
8.3. Analysis By End-user
8.4. Hospitals Historic and Forecast Sales By Regions
8.5. Cardiac Centers Historic and Forecast Sales By Regions
8.6. Ambulatory Surgical Centers Historic and Forecast Sales By Regions

9. GLOBAL BIOABSORBABLE STENTS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BIOABSORBABLE STENTS COMPANIES

10.1. Bioabsorbable Stents Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF BIOABSORBABLE STENTS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Amaranth Medical
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Arterial Remodeling Technologies
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Arterius Limited
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. B.Braun Melsungen AG
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Biotronik SE & Co. KG
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Boston Scientific Corporation
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Elixir Medical Corporation
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Kyoto Medical Planning Co. Ltd.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Microport Scientific Corporation
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Reva Medical
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Terumo Corporation
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments